While animal studies show a good safety profile, a theoretical risk involving its pro-angiogenic effects and potential cancer promotion is a point of consideration, though no evidence has supported this risk in practice
Retrieved from FDA
This enabled commercial use even without full drug approval
Reconstitution Troubleshooting Quality Verification Checklist Before using reconstituted IGF-1 LR3 in experiments: [ ] Confirm lot certificate of analysis (HPLC purity 98%, mass spec identity) [ ] Document reconstitution date, solvent, concentration, volume [ ] Visual inspection: solution is clear and colorless [ ] Aliquots labeled with compound, concentration, date, freeze-thaw count [ ] First-use aliquot shows expected biological activity in pilot assay For information on what certificates of analysis should contain, see: Quality Testing and Third-Party Verification for IGF-1 LR3 Research Peptides
The FDA has expressed concerns about compounded peptides, particularly those that have not been approved for any medical use
See Full Answer In terms of current official pharmacy offerings, providers often recommend Sermorelin as a good boost